Medication info
Maxzaltan Tablets 5/100 mg

Maxzaltan Tablets 5/100 mg

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.944mg / 1 tabletLosartan Potassium›100mg / 1 tablet
Manufacturer / importer
AlboGen Korea Co., Ltd.
Appearance
Pink rectangular film-coated tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201502969 · Approved 2015.05.18 · Insurance code 652604530

Summary

Main use
Initial treatment of stage 2 hypertension and essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. - 5/50 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 50 milligrams monotherapy. - 5/100 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 100 milligrams monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, the treatment goal, and the expected likelihood of achieving the treatment goal with combination therapy compared with monotherapy. The usual dose is 5/50 milligrams once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 milligrams once daily. ○ Patients with renal impairment: No dosage adjustment is required in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min), but administration of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced effective intravascular volume: Administration of this medicine is not recommended in the small number of patients with reduced effective intravascular volume (e.g., patients receiving high-dose diuretics). (See Precautions for Use, 1. Warnings.) ○ Patients with hepatic impairment: Administration of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 milligrams once daily). ○ Older adults: For patients aged 75 years or older, an initial dose of losartan of 25 milligrams once daily is recommended; therefore, this medicine is not recommended as initial therapy.
Child dose
○ Children: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
AlboGen Korea Co., Ltd.

Efficacy & effects

Initial treatment of stage 2 hypertension and essential hypertension not controlled with monotherapy

  • Essential hypertension
  • stage 2 hypertension
View approved original text

This medication is suitable for patients with essential hypertension whose blood pressure is not sufficiently controlled by monotherapy with Amlodipine or Losartan. It is also used for initial treatment in patients with stage 2 hypertension who require combination therapy to reach their target blood pressure. This drug effectively manages hypertension and stabilizes blood pressure.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. - 5/50 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 50 milligrams monotherapy. - 5/100 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 100 milligrams monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, the treatment goal, and the expected likelihood of achieving the treatment goal with combination therapy compared with monotherapy. The usual dose is 5/50 milligrams once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 milligrams once daily. ○ Patients with renal impairment: No dosage adjustment is required in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min), but administration of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced effective intravascular volume: Administration of this medicine is not recommended in the small number of patients with reduced effective intravascular volume (e.g., patients receiving high-dose diuretics). (See Precautions for Use, 1. Warnings.) ○ Patients with hepatic impairment: Administration of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 milligrams once daily). ○ Older adults: For patients aged 75 years or older, an initial dose of losartan of 25 milligrams once daily is recommended; therefore, this medicine is not recommended as initial therapy.

Child dose

○ Children: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus when taken during pregnancy, particularly during the second and third trimesters; therefore, it should be discontinued immediately if pregnancy is confirmed. Patients with reduced intravascular effective blood volume, such as those on diuretics, should stabilize their condition before starting this medication to minimize the risk of hypotension. Patients with allergies to the components of this medication or with severe liver dysfunction, severe aortic stenosis, or in a state of shock should not take this medication. Due to the blood pressure-lowering effect, dizziness or drowsiness may occur, so hazardous activities such as working at heights or driving should be avoided. This medication is used to treat hypertension, and during treatment, regular monitoring of blood pressure, renal function, and electrolyte levels is recommended to detect adverse reactions early. Additionally, caution is needed when taking this medication with potassium-sparing diuretics or potassium supplements, as it may increase potassium levels in the blood. This medication is not recommended for breastfeeding women, and its safety or proper dosage has not been established in children or elderly patients over 75 years of age, so caution is warranted. In case of overdose, severe hypotension and tachycardia may occur, requiring immediate medical attention. Taking this medication with grapefruit juice may enhance the blood pressure-lowering effect, so it is advisable to avoid this combination. If abnormal symptoms occur during use, consult healthcare professionals immediately for appropriate measures.

Side effects

  • Hypotension
  • neonatal skull formation impairment
  • anuria
  • renal failure
  • oligohydramnios
  • fetal limb twitching
  • craniofacial deformities
  • pulmonary hypoplasia
  • prematurity
  • intrauterine growth retardation
Show 204 more
  • patent ductus arteriosus
  • dizziness
  • headache
  • drowsiness
  • cerebral infarction
  • weakness
  • chest discomfort
  • chest pain
  • early satiety
  • peripheral edema
  • pit edema
  • abdominal discomfort
  • dyspepsia
  • nausea
  • gastroesophageal reflux
  • constipation
  • pruritus
  • urticaria
  • palpitations
  • flushing
  • orthostatic hypotension
  • facial flushing
  • dyspnea
  • cough
  • conjunctival injection
  • frequent urination
  • fatigue
  • swelling
  • vertigo
  • abdominal pain
  • nausea
  • weakness
  • lethargy
  • pain
  • weight gain
  • weight loss
  • hypotension
  • vasculitis
  • muscle tension
  • sensory loss
  • sensory abnormalities
  • peripheral neuropathy
  • syncope
  • taste disorders
  • tremors
  • erectile dysfunction
  • gynecomastia
  • changes in bowel habits
  • dry mouth
  • gastritis
  • gingival hypertrophy
  • pancreatitis
  • vomiting
  • hyperglycemia
  • arthralgia
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • cough
  • rhinitis
  • hair loss
  • increased sweating
  • purpura
  • skin discoloration
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urinary frequency
  • urination disorders
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • constipation
  • dermatitis
  • maculopapular rash
  • heaviness
  • warmth
  • impaired glucose tolerance
  • weakness
  • muscle cramps
  • low back pain
  • limb pain
  • congestion
  • upper respiratory infection
  • sinusitis
  • diarrhea
  • sinus disorders
  • pharyngitis
  • myalgia
  • insomnia
  • edema
  • abdominal pain
  • angioedema
  • skin peeling
  • hemolysis
  • facial edema
  • fever
  • orthostatic effect
  • syncope
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • appetite loss
  • toothache
  • flatulence
  • gastritis
  • anemia
  • gout
  • upper limb pain
  • hip pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthralgia
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory reduction
  • decreased libido
  • memory impairment
  • migraine
  • neuroexcitability
  • panic disorder
  • sleep disorder
  • tremors
  • bronchitis
  • throat discomfort
  • nosebleed
  • rhinitis
  • respiratory congestion
  • hair loss
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • photosensitivity
  • rash
  • sweating
  • urticaria
  • blurred vision
  • burning and pain in the eyes
  • conjunctivitis
  • dysgeusia
  • tinnitus
  • decreased vision
  • erectile dysfunction
  • nocturia
  • urethral infection
  • dry cough
  • angioedema
  • vasculitis
  • anaphylactic reaction
  • liver function abnormalities
  • intestinal vascular edema
  • lethargy
  • thrombocytopenia
  • rhabdomyolysis
  • taste disorders
  • erythroderma
  • hyperkalemia
  • hyponatremia
  • ALT elevation
  • increased serum creatinine
  • hypotension
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • anaphylactoid syndrome
  • excessive peripheral vasodilation
  • reflex tachycardia
  • systemic hypotension
  • shock
  • bradycardia
  • hypotension
  • tachycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to avoid exposure to air or moisture. It is advisable to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

Pink rectangular film-coated tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.